For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation between the US and the EU.

On his part, Madbouly emphasized that this meeting aims to follow up on efforts to advance the pharmaceutical industry ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...

The US has imposed a steep 25 per cent tariff on Indian goods, targeting key export sectors like textiles, diamonds, and auto ...

Risk assessment for potential mutagenic side-products is still required by regulatory bodies, despite lack of evidence they ...

Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.

Iraq's drug localization efforts save $1B annually, with 34 factories at full capacity & 178 new applications, says PM's ...

The Saudi Food and Drug Authority (SFDA) has approved Agios' Pyrukynd (mitapivat) for adults with alpha or beta-thalassemia.

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...